FOXA2 and hepatocellular carcinoma: Moreover, propofol was found to decrease LPS-induced production of monocyte chemoattractant protein-1 (a cytokine that mediates cell influx to inflammatory sites) via increasing expression of apoM and forkhead box protein A2 (foxa2) in human liver carcinoma (HepG2) cells [8].